Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ · Manufacturing · Pharmaceutical preparations
ZNTL price, last 12 months
Key stats
- Previous close
- $1.36
- Open
- $1.40
- Day range
- $1.30 – $1.42
- 52-week range
- $1.28 – $6.95
- Volume
- 1.4M
- Avg volume (20 days)
- 1.4M
- Market cap
- $167.1M
Performance
Technicals and fundamentals
About Zentalis Pharmaceuticals, Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $167.1M